From the Cincinnati Business Journal: Procter denies scientist's challenge on drug claims. A snip:
- A researcher hired by Procter & Gamble Co. to analyze its Actonel osteoporisis drug is meeting with U.S. officials this week to argue that the consumer products maker misrepresented his data, the Wall Street Journal reported today.
The scientist, Aubrey Blumsohn, a bone-metabolism expert at the University of Sheffield in the United Kingdom, claims Procter distorted his data about the drug's effectiveness in its educational and marketing materials. He is meeting with congressional staffers and the National Institutes for Health.